Comprehensive hematology and stem cell research /

Comprehensive Hematology and Stem Cell Research is the first major reference to cover both stem cell research and therapy as well as the range of hematological disorders they are currently used to treat and may potentially be able to treat in the future. This five volume set includes fundamentals, s...

Full description

Bibliographic Details
Corporate Author: ScienceDirect (Online service)
Other Authors: Rezaei, Nima (Editor)
Format: eBook
Language:English
Published: Amsterdam : Elsevier, 2024.
Subjects:
Online Access:Connect to the full text of this electronic book
Table of Contents:
  • 9780443157189v1_WEB
  • Front Cover
  • COMPREHENSIVE HEMATOLOGY AND STEM CELL RESEARCH
  • COMPREHENSIVE HEMATOLOGY AND STEM CELL RESEARCH
  • Copyright
  • CONTENTS OF VOLUME 1
  • DEDICATION
  • EDITOR-IN-CHIEF BIOGRAPHY
  • EDITORIAL BOARD
  • CONTRIBUTORS TO VOLUME 1
  • PREFACE
  • 1.01
  • Introduction to Hematological Disorders
  • 1.01.1 Introduction
  • 1.01.2 Background and Fundamentals
  • 1.01.2.1 Basic Blood Components and Classifications
  • 1.01.2.2 Basics of Hematopoiesis and Blood Cells Differentiation
  • 1.01.2.2.1 Embryonic Stage
  • 1.01.2.2.2 Adult
  • 1.01.2.3 Basic Hematology Laboratory Evaluations
  • 1.01.3 Tutorial Review of the Field
  • 1.01.4 Results and Discussion
  • 1.01.4.1 Non-malignant Conditions
  • 1.01.4.1.1 Abnormal CBC
  • Anemia, Thrombocytopenia, Leukocytosis, and Leukopenia
  • 1.01.4.1.1.1 Clinical Presentation
  • 1.01.4.1.1.2 Basic Etiology, Diagnosis, Laboratory Changes, and Related Treatments
  • 1.01.4.1.1.2.1 Frequent Etiology Associated With Anemia and Common CBC Alterations and Management/Treatment
  • 1.01.4.1.1.2.2 Anemia Diagnosis and Laboratory Changes
  • 1.01.4.1.2 Sickle Cell Disease
  • 1.01.4.1.2.1 Clinical Presentation
  • 1.01.4.1.2.2 Basic Etiology, Diagnosis, and Laboratory Changes
  • 1.01.4.1.2.2.1 Basic Etiology and Pathophysiology
  • 1.01.4.1.2.2.2 Diagnosis, Screening, and Laboratory Findings
  • 1.01.4.1.2.3 Treatment
  • 1.01.4.1.2.3.1 Management of Acute SCD Complications
  • 1.01.4.1.2.3.2 Management of Chronic SCA Complications
  • 1.01.4.1.3 Thalassemia
  • 1.01.4.1.3.1 Clinical Presentation
  • 1.01.4.1.3.2 Basic Etiology, Diagnosis, and Laboratory Changes
  • 1.01.4.1.3.3 Treatment
  • 1.01.4.1.4 Hemorrhagic Disorders
  • 1.01.4.1.4.1 Clinical Presentation
  • 1.01.4.1.4.1.1 Hemophilia
  • 1.01.4.1.4.1.2 Von Willebrand Disease (VWD)
  • 1.01.4.1.4.2 Basic Etiology, Diagnosis, and Laboratory Changes
  • 1.01.4.1.4.3 Treatment
  • 1.01.4.2 Malignant Conditions
  • 1.01.4.2.1 Classifications and Basic Physiopathology
  • 1.01.4.2.2 Overview of Hematological Malignancies
  • 1.01.4.2.2.1 Lymphoid
  • 1.01.4.2.2.1.1 ALL
  • 1.01.4.2.2.1.2 CLL
  • 1.01.4.2.2.1.3 HCL
  • 1.01.4.2.2.1.4 Lymphomas
  • 1.01.4.2.2.2 Myeloid
  • 1.01.4.2.2.2.1 Hodgkin Lymphoma (HL)
  • 1.01.4.2.2.2.2 Non-Hodgkin Lymphoma (NHL)
  • 1.01.4.2.2.3 Myeloid
  • 1.01.4.2.2.3.1 AML
  • 1.01.4.2.2.3.2 CML
  • 1.01.4.2.2.3.3 MDS
  • 1.01.4.2.2.3.4 MM
  • 1.01.4.2.3 Molecular Diagnosis in Hematological Malignancies: An Overview
  • 1.01.5 Future Directions
  • 1.01.6 Closing Remarks
  • Acknowledgment
  • References
  • Further Reading
  • Relevant Websites
  • 1.02
  • Inherited Bone Marrow Failure Syndromes
  • 1.02.1 Introduction
  • 1.02.2 Fanconi Anemia
  • 1.02.2.1 Prevalence
  • 1.02.2.2 Clinical Presentation
  • 1.02.2.2.1 Cancer Risk
  • 1.02.2.3 Pathophysiology and Genetics
  • 1.02.2.4 Diagnostic Testing
  • 1.02.2.5 Treatment and Management
  • 1.02.2.5.1 Hematopoietic Stem Cell Transplant (HSCT)